| Literature DB >> 34300168 |
Michelle T Bover Manderski1,2, Michael B Steinberg3,4, Olivia A Wackowski2,5, Binu Singh2, William J Young2, Cristine D Delnevo2,5.
Abstract
We conducted a survey experiment among US physicians to evaluate whether question wording impacted perceptions about the health effects of nicotine. 926 physicians were randomized to receive one of two versions of a question matrix that asked about the "extent to which they agree or disagree that 'nicotine' (Version 1) or 'nicotine, on its own,' (Version 2) directly contributes to" birth defects, cardiovascular disease (CVD), cancer, depression, and chronic obstructive pulmonary disease (COPD). We evaluated whether question condition predicted strong agreement and/or agreement with each statement, and assessed demographic correlates of each outcome while adjusting for question version. Physicians who received Version 2 were less likely to "strongly agree" that nicotine directly caused birth defects (Prevalence Ratio (PR) 0.84, 95% CI 0.72-0.98), CVD (PR 0.89, 95% CI 0.84-0.95), cancer (PR 0.81, 95% CI 0.75-0.87), and COPD (PR 0.78, 95% CI 0.72-0.84). Females were more likely to "strongly agree" that nicotine directly contributes to birth defects and cancer, and family physicians were most likely to "strongly agree" that nicotine directly contributes to CVD, cancer, and COPD. Question wording is important when measuring physicians' beliefs about nicotine; however, even after accounting for question version, misperceptions about the direct health effects of nicotine were common and varied by sex and specialty.Entities:
Keywords: nicotine; perceptions; physicians; survey
Mesh:
Substances:
Year: 2021 PMID: 34300168 PMCID: PMC8306881 DOI: 10.3390/ijerph18147713
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sample Characteristics by Question Version, (N = 926).
| Overall | Question Version | ||||||
|---|---|---|---|---|---|---|---|
| Version 1 (n = 461) | Version 2 (n = 465) | ||||||
|
| % |
| % |
| % | ||
| Age, years c | |||||||
| Median (IQR) | 51.0 | (15.0) | 51.0 | (15.0) | 52.0 | (16.0) | 0.6586 |
| Gender | |||||||
| Female | 450 | 50.6% | 221 | 49.4% | 229 | 51.7% | 0.5016 |
| Male | 440 | 49.4% | 226 | 50.6% | 214 | 48.3% | |
| Race/Ethnicity | |||||||
| Non-Hispanic White | 592 | 66.8% | 289 | 64.7% | 303 | 69.0% | 0.1356 |
| Non-Hispanic Black | 44 | 5.0% | 30 | 6.7% | 14 | 3.2% | |
| Hispanic | 41 | 4.6% | 18 | 4.0% | 23 | 5.2% | |
| Non-Hispanic Asian/PI | 108 | 12.2% | 53 | 11.9% | 55 | 12.5% | |
| Non-Hispanic South Asian | 55 | 6.2% | 31 | 6.9% | 24 | 5.5% | |
| Non-Hispanic Other | 46 | 5.2% | 26 | 5.8% | 20 | 4.6% | |
| Graduation year d | |||||||
| Median (IQR) | 1995.0 | (17.0) | 1996.0 | (16.0) | 1994.0 | (17.0) | 0.6097 |
| Specialty | |||||||
| Family Medicine | 343 | 37.0% | 178 | 38.6% | 165 | 35.5% | 0.5746 |
| Internal Medicine | 255 | 27.5% | 126 | 27.3% | 129 | 27.7% | |
| OB/GYN | 328 | 35.4% | 157 | 34.1% | 171 | 36.8% | |
SD, Standard Deviation; IQR, Interquartile Range. a Frequencies may not total 926 due to item nonresponse. b Characteristics compared by question version using Pearson chi-square (for categorical variables) or two-sided Wilcoxon Rank-Sum (for continuous variables) test. c Imputed for 7 respondents as median age within same specialty and graduation year. d Imputed for 21 respondents as median year within same specialty and age.
Distribution of Responses to Nicotine Questions, by Question Version (N = 926).
| Question Version | |||||
|---|---|---|---|---|---|
| Version 1 (n = 461) | Version 2 (n = 465) | ||||
|
| % |
| % | ||
| Birth Defects | |||||
| Mean a ± SD | 3.14 | ±0.97 | 3.01 | ±0.98 | 0.0247 |
| Strongly Disagree | 37 | 8.1% | 42 | 9.1% | |
| Disagree | 76 | 16.6% | 92 | 19.9% | |
| Agree | 131 | 28.6% | 148 | 32.0% | |
| Strongly Agree | 214 | 46.7% | 180 | 39.0% | |
| CVD | |||||
| Mean a ± SD | 3.78 | ±0.64 | 3.64 | ±0.79 | 0.0005 |
| Strongly Disagree | 13 | 2.8% | 22 | 4.7% | |
| Disagree | 15 | 3.3% | 24 | 5.2% | |
| Agree | 32 | 6.9% | 55 | 11.9% | |
| Strongly Agree | 401 | 87.0% | 363 | 78.2% | |
| Cancer | |||||
| Mean a ± SD | 3.70 | ±0.77 | 3.45 | ±0.93 | <0.0001 |
| Strongly Disagree | 23 | 5.0% | 30 | 6.5% | |
| Disagree | 21 | 4.6% | 52 | 11.2% | |
| Agree | 25 | 5.4% | 59 | 12.7% | |
| Strongly Agree | 392 | 85.0% | 322 | 69.6% | |
| Depression | |||||
| Mean a ± SD | 2.82 | ±0.87 | 2.79 | ±0.85 | 0.5378 |
| Strongly Disagree | 32 | 7.1% | 32 | 7.0% | |
| Disagree | 121 | 26.7% | 127 | 27.7% | |
| Agree | 196 | 43.3% | 206 | 44.9% | |
| Strongly Agree | 104 | 23.0% | 94 | 20.5% | |
| COPD | |||||
| Mean a ± SD | 3.69 | ±0.80 | 3.36 | ±1.02 | <0.0001 |
| Strongly Disagree | 23 | 5.0% | 42 | 9.1% | |
| Disagree | 27 | 5.9% | 62 | 13.4% | |
| Agree | 18 | 3.9% | 47 | 10.2% | |
| Strongly Agree | 391 | 85.2% | 311 | 67.3% | |
a Strongly agree = 4, Agree = 3, Disagree = 2, Strongly Disagree = 1. b 2-sided Wilcoxon Rank-Sum Test.
Prevalence of and multivariable associations with “strongly agreeing” that nicotine directly contributes to each health effect.
| Birth Defects | CVD | Cancer | Depression | COPD | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | ||||||
| Question | ||||||||||||||||||||
| Original | 46.7% | Ref. | 87.0% | Ref. | 85.0% | Ref. | 23.0% | Ref. | 85.2% | Ref. | ||||||||||
| Modified | 39.0% | 0.84 | (0.72, 0.98) | 78.2% | 0.89 | (0.84, 0.95) | 69.6% | 0.81 | (0.75, 0.87) | 20.5% | 0.90 | (0.69, 1.16) | 67.3% | 0.78 | (0.72, 0.84) | |||||
| Sex | ||||||||||||||||||||
| Male | 39.9% | Ref. | 79.5% | Ref. | 73.9% | Ref. | 21.8% | Ref. | 72.5% | Ref. | ||||||||||
| Female | 43.9% | 1.19 | (1.01, 1.39) | 84.8% | 1.04 | (0.98, 1.10) | 79.8% | 1.08 | (1.01, 1.15) | 20.4% | 0.91 | (0.69, 1.19) | 78.7% | 1.06 | (0.99, 1.14) | |||||
| Age | ||||||||||||||||||||
| Per 5 Years | --- | 0.97 | (0.94, 1.01) | --- | 1.00 | (0.99, 1.02) | --- | 1.00 | (0.99, 1.02) | --- | 0.96 | (0.90, 1.03) | --- | 1.01 | (0.99, 1.02) | |||||
| Specialty | ||||||||||||||||||||
| Family | 51.0% | 1.74 | (1.41, 2.13) | 89.2% | Ref. | 82.2% | Ref. | 22.2% | Ref. | 81.1% | Ref. | |||||||||
| Internal | 48.4% | 1.69 | (1.35, 2.11) | 75.6% | 0.84 | (0.78, 0.92) | 71.2% | 0.86 | (0.78, 0.94) | 22.8% | 1.05 | (0.76, 1.46) | 68.9% | 0.85 | (0.77, 0.94) | |||||
| OB/GYN | 29.9% | Ref. | 81.1% | 0.92 | (0.87, 0.98) | 76.8% | 0.94 | (0.88, 1.01) | 20.4% | 0.94 | (0.69, 1.29) | 76.9% | 0.95 | (0.89, 1.02) | ||||||
aPR, Prevalence Ratio (adjusted for all variables in table); CI, Confidence Interval.
Figure 1Association between question version and “strongly agreeing” that nicotine directly contributes to each health effect. Adjusted for age, gender, and specialty.
Prevalence of and multivariable associations with “agreeing” or “strongly agreeing” that nicotine directly contributes to each health effect.
| Birth Defects | CVD | Cancer | Depression | COPD | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | % | aPR | (95% CI) | ||||||
| Question | ||||||||||||||||||||
| Original | 75.3% | Ref. | 93.9% | Ref. | 90.5% | Ref. | 66.2% | Ref. | 89.1% | Ref. | ||||||||||
| Modified | 71.0% | 0.94 | (0.88, 1.01) | 90.1% | 0.95 | (0.92, 0.99) | 82.3% | 0.89 | (0.85, 0.94) | 65.4% | 1.00 | (0.91, 1.10) | 77.5% | 0.86 | (0.81, 0.91) | |||||
| Sex | ||||||||||||||||||||
| Male | 71.1% | Ref. | 88.9% | Ref. | 82.8% | Ref. | 61.6% | Ref. | 79.7% | Ref. | ||||||||||
| Female | 74.0% | 1.07 | (1.00, 1.16) | 94.6% | 1.04 | (1.00, 1.08) | 88.9% | 1.04 | (0.99, 1.09) | 68.7% | 1.08 | (0.98, 1.19) | 85.8% | 1.05 | (0.99, 1.11) | |||||
| Age | ||||||||||||||||||||
| Per 5 Years | --- | 0.99 | (0.97, 1.01) | --- | 1.00 | (0.99, 1.01) | --- | 1.00 | (0.98, 1.01) | --- | 0.96 | (0.93, 0.98) | --- | 1.00 | (0.99, 1.02) | |||||
| Specialty | ||||||||||||||||||||
| Family | 84.0% | 1.48 | (1.33, 1.65) | 94.5% | Ref. | 90.1% | Ref. | 72.2% | Ref. | 86.6% | Ref. | |||||||||
| Internal | 78.2% | 1.40 | (1.24, 1.59) | 85.4% | 0.92 | (0.86, 0.98) | 79.5% | 0.88 | (0.81, 0.95) | 61.2% | 0.88 | (0.78, 1.00) | 76.8% | 0.89 | (0.82, 0.97) | |||||
| OB/GYN | 57.9% | Ref. | 94.5% | 1.01 | (0.98, 1.04) | 87.8% | 0.97 | (0.93, 1.02) | 62.7% | 0.87 | (0.78, 0.97) | 84.9% | 0.99 | (0.93, 1.04) | ||||||
aPR, Prevalence Ratio (adjusted for all variables in table); CI, Confidence Interval.